Sandoz INC
Pharmaceutical company
Based in NJ
AI Overview
With $2.4M in lobbying spend across 11 quarterly filings, Sandoz INC is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $80K |
| 2024 | $1.2M |
| 2025 | $1.1M |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sandoz INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid
Issues related to generic drug supply chain and shortage proposals, interchangeability proposals and PBM proposals
Generic drug supply chain and shortage proposals, interchangeability proposals and PBM proposals
Issues related to biosimilar legislation; PBM reform legislation; Generics sustainability and supply chain; House Oversight Committee Minority request re Amoxicillin shortage
Congressional outreach re: PBM reform legislation (biosimilars); Generics sustainability and supply chain; Biosimilars sustainability; Biosimilars interchangeability legislation
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.